ProKidney Corp.

1.02
-0.07 (-6.85%)
At close: Mar 04, 2025, 3:59 PM

ProKidney Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19
Net Income -135.45M -148.13M -55.15M -26.75M -79.61K
Depreciation & Amortization 3.17M 3.04M 1.98M 964K 867.00
Stock-Based Compensation 30.85M 74.47K 699.00 730.00 498.00
Other Working Capital 5.04M -6.95M 2.16M -809K -115
Other Non-Cash Items -5.31M 40.44M 4.66M 604.00 1.56K
Deferred Income Tax n/a -40.44M -4.66M -604 n/a
Change in Working Capital 16.67M -6.46M 2.16M -126K -115
Operating Cash Flow -90.07M -77.09M -50.3M -25.18M -76.81K
Capital Expenditures -34.2M -1.85M -5.19M -5.46M -1.3K
Acquisitions n/a 108K 1K n/a -1.66K
Purchase of Investments -471.6M n/a n/a n/a n/a
Sales Maturities Of Investments 175.82M n/a n/a n/a n/a
Other Investing Acitivies n/a 108K 1.00 n/a n/a
Investing Cash Flow -329.98M -1.74M -5.19M -5.46M -2.97K
Debt Repayment -52K -32K -30K -11K n/a
Common Stock Repurchased -9.5M n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies n/a 548.55M 71.5M 20M 20K
Financial Cash Flow -9.55M 548.52M 71.47M 19.99M 20K
Net Cash Flow -429.6M 469.69M 15.98M -10.65M 15.23K
Free Cash Flow -124.27M -78.94M -55.49M -30.64M -78.11K